Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Ferrara

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|August 1, 1994
Paradigm shift for graft-versus-host diseaseJ L Ferrara
Transfusion Medicine Reviews|February 14, 1998
Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokinesJ L Ferrara, W Krenger
Journal of Hematotherapy|February 1, 1996
Dysregulation of cytokines during graft-versus-host diseaseW Krenger, J L Ferrara
Immunologic Research|January 1, 1996
Graft-versus-host disease and the Th1/Th2 paradigmW Krenger, J L Ferrara
Blood|April 26, 2000
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantationG R Hill, J L Ferrara
Blood|December 15, 1992
Cytokine dysregulation and acute graft-versus-host diseaseJ H Antin, J L Ferrara
The New England Journal of Medicine|March 7, 1991
Graft-versus-host diseaseJ L Ferrara, H J Deeg
Cancer Treatment and Research|May 9, 2000
Monoclonal antibody and receptor antagonist therapy for GVHDJ L Ferrara, E Holler, B Blazar
Transplantation|August 27, 1997
Cytokine cascades in acute graft-versus-host diseaseW Krenger, G R Hill, J L Ferrara
Hematology (Amsterdam, Netherlands)|July 15, 2016
Cytokine Dysregulation in Acute Graft-versus-Host DiseaseG R Hill, W Krenger, J L Ferrara
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|August 1, 1994
Paradigm shift for graft-versus-host diseaseJ L Ferrara
Transfusion Medicine Reviews|February 14, 1998
Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokinesJ L Ferrara, W Krenger
Journal of Hematotherapy|February 1, 1996
Dysregulation of cytokines during graft-versus-host diseaseW Krenger, J L Ferrara
Immunologic Research|January 1, 1996
Graft-versus-host disease and the Th1/Th2 paradigmW Krenger, J L Ferrara
Blood|April 26, 2000
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantationG R Hill, J L Ferrara
Blood|December 15, 1992
Cytokine dysregulation and acute graft-versus-host diseaseJ H Antin, J L Ferrara
The New England Journal of Medicine|March 7, 1991
Graft-versus-host diseaseJ L Ferrara, H J Deeg
Cancer Treatment and Research|May 9, 2000
Monoclonal antibody and receptor antagonist therapy for GVHDJ L Ferrara, E Holler, B Blazar
Transplantation|August 27, 1997
Cytokine cascades in acute graft-versus-host diseaseW Krenger, G R Hill, J L Ferrara
Hematology (Amsterdam, Netherlands)|July 15, 2016
Cytokine Dysregulation in Acute Graft-versus-Host DiseaseG R Hill, W Krenger, J L Ferrara
Pageof 9